$PLBC

PLUMAS BANCORP (PLBC): Results of Operations and Financial Condition

PLUMAS BANCORP (PLBC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex_987726.htm EXHIBIT 99.1 ex_987726.htm Exhibit 99.1 PLUMAS BANCORP REPORTS RECORD SECOND QUARTER 2026 EARNINGS Reno, Nevada, July 15, 2026 – Plumas Bancorp (Nasdaq:PLBC) referred to herein as the ‘Company,’ the parent company of Plumas Bank, today announced record ear

Original reporting
Published Jul 15, 2026, 1:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 15, 2026, 1:04 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$PLBC
Bullish
medium confidence
Mentioned
$PLBC
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$PLBCBullishMed
01

Why it matters

The most tradable elements are the record earnings print, the direction of net interest income and credit-loss provision, and the acquisition-driven jump in loans and deposits, which together affect near-term earnings power and credit risk perception.

02

Market read

Record Q2 earnings and improved credit-loss provision, paired with large loan and deposit growth from the Cornerstone acquisition, are likely to be the primary drivers of investor repricing.

03

What to watch

Deposit growth includes a large share of non-interest-bearing demand deposits, but the mix and sustainability of those balances are not fully detailed here; asset-quality commentary is qualitative rather than quantified beyond the provision.

Relevance 7/10Novelty 7/10Timing: after-hours/filing-day digest of Q2 2026 results on SEC 8-K

Background

This SEC 8-K includes Item 2.02 results for Q2 2026 and highlights performance plus balance-sheet changes that primarily reflect the Cornerstone Community Bank acquisition effective July 1, 2025.

Company-level read

Ticker impact

$PLBCBullishMedium confidence
Context

Plumas Bancorp reported record Q2 2026 earnings of $9.9M, with net interest income up to $26.0M and credit-loss provision down to $600K.

Expected impact

Moderately positive bias for the next trading session and subsequent days as investors digest the earnings and acquisition-driven balance-sheet expansion.

Evidence & confidence

The filing provides multiple concrete datapoints (earnings, NII, credit-loss provision, ROA/ROE, and balance-sheet growth) that can re-rate expectations, but it is still a regional bank where price reaction may be muted by broader rate and credit-cycle concerns.

Market effects

Adds another datapoint on small-bank earnings resilience, with variable-rate loan mix and lower credit-loss provision supporting net interest and asset-quality narratives.

May influence sentiment toward community banks in the company’s operating footprint via evidence of deposit growth and acquisition integration.

Limited, as the disclosure is specific to a US regional bank and does not signal systemic macro changes.

Counterpoint

The expense increase and the heavy reliance on variable-rate loans indexed to T-bills could amplify earnings volatility if rate expectations shift.

Key entities

  • Plumas Bancorp

    Nasdaq-listed parent of Plumas Bank, reporting record Q2 2026 earnings and acquisition-driven balance-sheet growth.

  • Cornerstone Community Bank

    Wholly owned subsidiary of Cornerstone Community Bancorp, acquired effective July 1, 2025, driving much of the six- and three-month results.

Related articles

$PLBCMedAI 8/10

Plumas Bancorp Reports Record Second Quarter 2026 Earnings

Plumas Bancorp (Nasdaq:PLBC) reported record Q2 2026 net income of $9.9 million, or $1.43 per share, up from $6.3 million, or $1.07 per share in Q2 2025. Net interest income rose to $26.0 million, credit loss provision fell to $600k, and deposits and loans grew after its Cornerstone acquisition. Six-month net income increased to $19.7 million.

$PLBCMed

Plumas Bancorp (NASDAQ:PLBC) Share Price Crosses Above 200

Plumas Bancorp (NASDAQ:PLBC) shares rose above their 200-day moving average on Wednesday, trading up to $53.21 and last at $52.84. The stock has a 200-day average near $48.40. Analysts cited include Stephens raising its target to $60 and Piper Sandler to $63. In April 15 earnings, PLBC reported $1.38 EPS and $28.14M revenue.

$SPGMedAI 8/10

Why Simon Property Group’s malls are attracting more retailers

Simon Property Group reported strong Q2 results with revenue up 20% to $1.79B. CEO Eli Simon noted high retailer demand, 1,200 leases signed, and 17% positive rent spreads. Portfolio occupancy remained at 96%, with re-leased Saks Off 5th space expected to yield higher rents. FFO was flat at $1.185B, while net income decreased 13.1% to $483.1M. Sales productivity rose 14% to $838 per sq ft.

$GILDHighAI 8/10

Gilead’s Core Business Is Accelerating, But Will Its $11 Billion Pipeline Bet Pay Off?

Gilead Sciences (GILD) reported Q2 2026 with double-digit growth in commercial portfolio sales, but posted a significant loss due to $11.2B in R&D expenses from acquisitions. HIV sales rose 12% to $5.7B, while non-HIV areas like liver disease and cancer treatments also showed growth. The company raised its 2026 sales guidance and made strategic acquisitions, but faces risks from clinical development and financial obligations.

$ABBVMedAI 8/10

AbbVie’s Humira Replacement Strategy Is Working, But Could Growth Be Too Concentrated?

AbbVie (NYSE:ABBV) reported Q2 2026 revenue of $16.99B, up 10.2%, driven by immunology and neuroscience. Skyrizi and Rinvoq revenues grew 24.4% and 24.5% respectively, offsetting Humira's 35.9% decline. However, concentration risk exists as these two products made up 47% of revenue. Oncology and aesthetics showed weaker performance, with oncology revenue down 1.5%. Adjusted EPS rose 22.9% to $3.65.